𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical impact of antibody formation to botulinum toxin A in children

✍ Scribed by Jochen Herrmann; Katrin Geth; Volker Mall; Hans Bigalke; Jürgen Schulte Mönting; Michaela Linder; Jan Kirschner; Steffen Berweck; Rudolf Korinthenberg; Florian Heinen; Urban M. Fietzek

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
68 KB
Volume
55
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The EDB Test—A clinical test for the det
The EDB Test—A clinical test for the detection of antibodies to botulinum toxin type A
✍ Kirn R. Kessler; Dr. Reiner Benecke 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

## Abstract Approximately 5 to 10% of patients with cervical, segmental or multifocal dystonia receiving repetitive local injections with botulinum toxin A (BTX A) are estimated to develop secondary loss of treatment benefit (nonresponding) because of the formation of circulating serum antibodies a

Use of botulinum toxin type F injections
Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
✍ Dr. Paul E. Greene; Stanley Fahn 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after

Secondary nonresponsiveness to botulinum
Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test
✍ Carla Cordivari; Vijay Peter Misra; Angela Vincent; Santiago Catania; Kailash P. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract We studied 20 patients with cervical dystonia who had started to respond poorly to botulinum toxin A (BTXA) injections after an initial good response. All patients had extensor digitorum brevis (EDB) tests performed in addition to BTXA immunoprecipition assay (IPA) and mouse bioassay (M

Variability of the immunologic and clini
Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections
✍ Charulata Sankhla; Dr. Joseph Jankovic; Drake Duane 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Immunoresistance (Ab+) to botulinum toxin type A (BTX-A) has been a serious concern since the introduction of BTX-A in the treatment of dystonia and other disorders associated with abnormal muscle contractions. We studied seven patients who developed Ab+ and later reverted to antibody-negative (Ab-)

Development of resistance to botulinum t
Development of resistance to botulinum toxin type A in patients with torticollis
✍ Dr. Paul Greene; Stanley Fahn; Beverly Diamond 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

## Abstract Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of these 559 patients (4.3%) had serological evidence of antibodies to btx by mouse neutralization assay. Some of the 559 patients had only one or two injection se